from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo
acute myeloid leukemia. Leukemia 2006; 20: 404–409. 3 Ohno R, Tomonaga M, Kobayashi
T, Kanamaru A, Shirakawa S, Masaoka T et al. Effect of granulocyte colony-stimulating factor
after intensive induction therapy in relapsed or refractory acute leukemia.